Clinical Performance Evaluation of T-TAS 01 PL Chip
Sponsor: Fujimori Kogyo Co., Ltd.
Listed as NCT03621020, this observational or N/A phase trial focuses on Congenital Platelets Abnormality and Healthy and remains completed. Sponsored by Fujimori Kogyo Co., Ltd., it has been updated 12 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Mar 2020 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Feb 2020 — Mar 2020 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Jan 2020 — Feb 2020 [monthly]
Recruiting
-
Oct 2019 — Jan 2020 [monthly]
Recruiting
-
Aug 2019 — Oct 2019 [monthly]
Recruiting
-
May 2019 — Aug 2019 [monthly]
Recruiting
-
Mar 2019 — May 2019 [monthly]
Recruiting
-
Dec 2018 — Mar 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2018 — Dec 2018 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fujimori Kogyo Co., Ltd.
- Hikari Dx, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .